HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

4,4',6-trimethylangelicin

new monofunctional furocoumarin; potential agent for photochemotherapy of psoriasis; capable of photoreacting with DNA to a large extent forming only monoadducts; produces singlet oxygen to an insignificant extent; structure given in first source
Also Known As:
4,4',6-TMA; 4,6,4'-TMA; 4,6,4'-trimethylangelicin; 2H-Furo(2,3-h)-1-benzopyran-2-one, 4,6,9-trimethyl-, (5Z,11alpha,13E,15S)-
Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Conconi, Maria Teresa: 1 article (01/2021)
2. Di Liddo, Rosa: 1 article (01/2021)
3. Menilli, Luca: 1 article (01/2021)
4. Miolo, Giorgia: 1 article (01/2021)
5. Sturaro, Giulio: 1 article (01/2021)
6. Tasso, Alessia: 1 article (01/2021)
7. Dobrucki, Jurek: 1 article (02/2005)
8. Rajwa, Bartek: 1 article (02/2005)
9. Sarna, Tadeusz: 1 article (02/2005)
10. Skrzeczyńska-Moncznik, Joanna: 1 article (02/2005)

Related Diseases

1. Carcinoma (Carcinomatosis)
2. Phototoxic Dermatitis (Phototoxicity)
3. Parapsoriasis
4. Mycosis Fungoides
5. Cystic Fibrosis (Mucoviscidosis)

Related Drugs and Biologics

1. Furocoumarins (Furanocoumarins)
2. Methoxsalen (Oxsoralen)
3. Chlorpromazine (Thorazine)

Related Therapies and Procedures

1. Photochemotherapy (Photodynamic Therapy)
2. PUVA Therapy